Derek Evans
Directeur Général chez TARGET PharmaSolutions, Inc.
Profil
Derek Evans is currently the Chief Executive Officer at TARGET PharmaSolutions, Inc. He completed his undergraduate degree at Clarkson University and his MBA at Fox School of Business.
Postes actifs de Derek Evans
| Sociétés | Poste | Début |
|---|---|---|
TARGET PharmaSolutions, Inc.
 TARGET PharmaSolutions, Inc. Miscellaneous Commercial ServicesCommercial Services TARGET Pharmasolutions, Inc. operates as a real-world data solutions company. It specializes in nonalcoholic steatohepatitis, hepatocellular carcinoma, inflammatory bowel disease, and primary biliary cholangitis. The company was founded by Margaret Powell and Michael W. Fried in February 2015 and is headquartered in Chapel Hill, NC. | Directeur Général | 01/11/2021 |
Formation de Derek Evans
| Fox School of Business | Masters Business Admin |
| Clarkson University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
TARGET PharmaSolutions, Inc.
TARGET PharmaSolutions, Inc. Miscellaneous Commercial ServicesCommercial Services TARGET Pharmasolutions, Inc. operates as a real-world data solutions company. It specializes in nonalcoholic steatohepatitis, hepatocellular carcinoma, inflammatory bowel disease, and primary biliary cholangitis. The company was founded by Margaret Powell and Michael W. Fried in February 2015 and is headquartered in Chapel Hill, NC. | Commercial Services |
